Aminoglycosides Market - Global Forecast 2026-2032

The aminoglycosides market remains essential for global healthcare, sustaining its role across acute and specialized infection management. Evolving pharmacological advances, shifting procurement challenges, and global regulatory changes are shaping patterns of use and operational strategies for senior stakeholders.

Market Snapshot: Aminoglycosides

The Aminoglycosides Market grew from USD 2.12 billion in 2025 to USD 2.21 billion in 2026. It is expected to continue growing at a CAGR of 4.91%, reaching USD 2.96 billion by 2032. This growth highlights the sustained clinical demand for these antibiotics and the evolving requirements for strategic sourcing, stewardship, and innovation. As antimicrobial resistance and changing trade environments influence supply and clinical protocols, aminoglycosides maintain a distinct position in therapeutic regimens worldwide.

Scope & Segmentation

Product Types: Amikacin, Gentamicin, Neomycin, Streptomycin, Tobramycin—each addresses distinctive clinical needs based on spectrum and toxicity profiles.
Administration Routes: Injectable (intramuscular, intravenous), oral (capsules, tablets), topical (eye drops, ear drops, skin creams).
Clinical Application Settings: Hospitals, ambulatory surgical centers, clinics—supporting both acute and outpatient regimens.
Distribution Pathways: Hospital pharmacies, retail outlets, online platforms, and wholesale distributors manage access and critical inventories.
Formulations: Ointment, powder, solution—with each influencing stability, shelf life, and handling requirements.
Regions: Americas; Europe, Middle East & Africa; Asia-Pacific—reflecting distinct procurement, regulatory, and clinical landscapes.
Technology Utilization: Advanced therapeutic drug monitoring, rapid diagnostics, cold chain systems, and integrated procurement analytics are increasingly central to safe and efficient use.

Key Takeaways

Clinical relevance of aminoglycosides remains strong for severe Gram-negative and selected Gram-positive infections, especially where rapid bactericidal action is critical.
Usage requires careful safety protocols due to nephrotoxicity and ototoxicity; decision-makers prioritize dosing strategies and drug monitoring to balance efficacy and minimize patient risk.
Recent stewardship programs and diagnostics advancements are redefining usage patterns, shifting focus toward targeted, short-course regimens guided by susceptibility data.
Supply chain resilience has moved to the forefront, with manufacturers and buyers diversifying suppliers, qualifying regional partnerships, and expanding inventory strategies to mitigate risks.
Regulatory scrutiny and tariff policies are prompting new sourcing tactics, investment in customs expertise, and strategic contracting to buffer against cost fluctuations and access interruptions.
Differentiated product development—such as stabilized formulations or specialized packaging—supports competitive positioning and addresses real-world clinical and logistics requirements.

Aminoglycosides Market: Tariff and Supply Chain Implications

The introduction of new United States tariff policies in 2025 is impacting procurement and manufacturing costs, compelling stakeholders to re-evaluate sourcing options and supplier geographies. Increased due diligence on alternative vendors, expanded domestic capacity, and strategic inventory management are common responses, resulting in downstream effects on working capital and lead times. Healthcare institutions are responding with proactive formulary adjustments and contingency protocols to safeguard clinical continuity during disruptions.

Methodology & Data Sources

This report employs a robust mixed-method research methodology, integrating primary interviews with infectious disease clinicians, hospital pharmacy leaders, and procurement experts, alongside a systematic secondary review of peer-reviewed literature and regulatory guidance. Segmentation mapping and case analysis underpin key findings.

Why This Report Matters

Enables data-driven strategic planning and informed procurement decisions for institutional buyers facing evolving clinical and tariff environments.
Provides actionable market segmentation, highlighting operational opportunities from technology adoption and supply diversification.
Equips manufacturers and distributors with insights for optimizing product portfolios and strengthening resilience to future disruptions.

Conclusion

Integrating stewardship, innovative formulations, and resilient supply strategies will empower stakeholders to maintain aminoglycoside accessibility and clinical value. Continued collaboration across supply, regulatory, and clinical domains remains essential for effective deployment.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Aminoglycosides Market, by Product Type

8.1. Amikacin
8.2. Gentamicin
8.3. Neomycin
8.4. Streptomycin
8.5. Tobramycin

9. Aminoglycosides Market, by Route Administration

9.1. Injectable
9.1.1. Intramuscular
9.1.2. Intravenous
9.2. Oral
9.2.1. Capsules
9.2.2. Tablets
9.3. Topical
9.3.1. Ear Drops
9.3.2. Eye Drops
9.3.3. Skin Creams

10. Aminoglycosides Market, by Application

10.1. Ambulatory Surgical Centers
10.2. Clinics
10.3. Hospital

11. Aminoglycosides Market, by Distribution Channel

11.1. Online
11.2. Offline

12. Aminoglycosides Market, by Formulation

12.1. Ointment
12.2. Powder
12.3. Solution

13. Aminoglycosides Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. Aminoglycosides Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Aminoglycosides Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States Aminoglycosides Market
17. China Aminoglycosides Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. AbbVie Inc.
18.6. AstraZeneca plc
18.7. Bristol Myers Squibb Company
18.8. Cipla Limited
18.9. GlaxoSmithKline plc
18.10. Hangzhou Uniwise International Co., Ltd.
18.11. HuvePharma
18.12. Insmed Incorporated
18.13. Jiangxi Bolai Pharmacy Co., Ltd.
18.14. Kremoint Pharma Pvt. Ltd
18.15. Medico Remedies Pvt. Ltd.
18.16. Medson Pharmaceuticals
18.17. Novartis AG
18.18. Pfizer Inc.
18.19. Teva Pharmaceutical Industries Ltd
18.20. Vega Pharma Ltd.
18.21. Zoetis Inc.

List of Figures

FIGURE 1. GLOBAL AMINOGLYCOSIDES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL AMINOGLYCOSIDES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL AMINOGLYCOSIDES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA AMINOGLYCOSIDES MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL AMINOGLYCOSIDES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY AMIKACIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY AMIKACIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY AMIKACIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY GENTAMICIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY GENTAMICIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY GENTAMICIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY NEOMYCIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY NEOMYCIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY NEOMYCIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY STREPTOMYCIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY STREPTOMYCIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY STREPTOMYCIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY TOBRAMYCIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY TOBRAMYCIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY TOBRAMYCIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY EAR DROPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY EAR DROPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY EAR DROPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY EYE DROPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY EYE DROPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY EYE DROPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY SKIN CREAMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY SKIN CREAMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY SKIN CREAMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY OINTMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY OINTMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY OINTMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY SOLUTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 82. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 88. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 100. LATIN AMERICA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 116. EUROPE AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. EUROPE AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 118. EUROPE AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 119. EUROPE AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 120. EUROPE AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 121. EUROPE AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 122. EUROPE AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 123. EUROPE AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 124. EUROPE AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 125. MIDDLE EAST AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. MIDDLE EAST AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 127. MIDDLE EAST AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 128. MIDDLE EAST AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 129. MIDDLE EAST AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 130. MIDDLE EAST AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 132. MIDDLE EAST AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 133. MIDDLE EAST AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 134. AFRICA AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. AFRICA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 136. AFRICA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 137. AFRICA AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 138. AFRICA AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 139. AFRICA AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 140. AFRICA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 141. AFRICA AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 142. AFRICA AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 153. ASEAN AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. ASEAN AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 155. ASEAN AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 156. ASEAN AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 157. ASEAN AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 158. ASEAN AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 159. ASEAN AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 160. ASEAN AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 161. ASEAN AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 162. GCC AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. GCC AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 164. GCC AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 165. GCC AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 166. GCC AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 167. GCC AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 168. GCC AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 169. GCC AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 170. GCC AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 171. EUROPEAN UNION AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. EUROPEAN UNION AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 173. EUROPEAN UNION AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 174. EUROPEAN UNION AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 175. EUROPEAN UNION AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 176. EUROPEAN UNION AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 177. EUROPEAN UNION AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 178. EUROPEAN UNION AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 179. EUROPEAN UNION AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 180. BRICS AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. BRICS AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 182. BRICS AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 183. BRICS AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 184. BRICS AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 185. BRICS AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 186. BRICS AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 187. BRICS AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 188. BRICS AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 189. G7 AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. G7 AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 191. G7 AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 192. G7 AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 193. G7 AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 194. G7 AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 195. G7 AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 196. G7 AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 197. G7 AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 198. NATO AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. NATO AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 200. NATO AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 201. NATO AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 202. NATO AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 203. NATO AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 204. NATO AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 205. NATO AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 206. NATO AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 207. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 209. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 210. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 211. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 212. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 213. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 214. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 215. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 216. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 217. CHINA AMINOGLYCOSIDES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 218. CHINA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 219. CHINA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 220. CHINA AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 221. CHINA AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 222. CHINA AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 223. CHINA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 224. CHINA AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 225. CHINA AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Aminoglycosides market report include:

AbbVie Inc.
AstraZeneca plc
Bristol Myers Squibb Company
Cipla Limited
GlaxoSmithKline plc
Hangzhou Uniwise International Co., Ltd.
HuvePharma
Insmed Incorporated
Jiangxi Bolai Pharmacy Co., Ltd.
Kremoint Pharma Pvt. Ltd
Medico Remedies Pvt. Ltd.
Medson Pharmaceuticals
Novartis AG
Pfizer Inc.
Teva Pharmaceutical Industries Ltd
Vega Pharma Ltd.
Zoetis Inc.

Table Information

Report Attribute	Details
No. of Pages	190
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 2.21 Billion
Forecasted Market Value ( USD ) by 2032	$ 2.96 Billion
Compound Annual Growth Rate	4.9%
Regions Covered	Global
No. of Companies Mentioned	18

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3511EUR$3,939USD£3,045GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3787EUR$4,249USD£3,285GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5133EUR$5,759USD£4,452GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6212EUR$6,969USD£5,387GBP

Market Snapshot: Aminoglycosides

Scope & Segmentation

Key Takeaways

Aminoglycosides Market: Tariff and Supply Chain Implications

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Aminoglycosides - Global Strategic Business Report

Aminoglycosides Market Report 2025

Aminoglycosides Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

Aminoglycosides Market Size, Share & Trends Analysis Report by Product (Neomycin, Tobramycin, Gentamicin), Route of Administration (Injectables, Feed, Intra-mammary), Application (Veterinary, Skin Infection), Region, with Growth Forecasts, 2025-2030

Antibacterial Drugs Market - Global Forecast 2026-2032